ARCHIVES

Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds

December 26, 2008

NiH Conference: More Discord Than Consensus At Statement’s Presentation

January 31, 1997

“Tone” Of Statement Lacks Balance, Klausner Says

January 31, 1997

DCPC To Merge Two Programs, Reorganizes Chemoprevention

November 4, 1994

In Brief: Resolution Seeks Two-Fold Increase For NIH; Hartwell Named President At Fred Hutchinson

January 31, 1997

Gramm-Rudman Cut Facing NCI Could Take $85 Million

October 20, 1989